124 related articles for article (PubMed ID: 3186986)
21. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
22. Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging.
Bomatí-Miguel O; Morales MP; Tartaj P; Ruiz-Cabello J; Bonville P; Santos M; Zhao X; Veintemillas-Verdaguer S
Biomaterials; 2005 Oct; 26(28):5695-703. PubMed ID: 15878375
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance relaxation properties of superparamagnetic particles.
Gossuin Y; Gillis P; Hocq A; Vuong QL; Roch A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):299-310. PubMed ID: 20049798
[TBL] [Abstract][Full Text] [Related]
24. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic iron oxide: pharmacokinetics and toxicity.
Weissleder R; Stark DD; Engelstad BL; Bacon BR; Compton CC; White DL; Jacobs P; Lewis J
AJR Am J Roentgenol; 1989 Jan; 152(1):167-73. PubMed ID: 2783272
[TBL] [Abstract][Full Text] [Related]
26. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Marchal G; Van Hecke P; Demaerel P; Decrop E; Kennis C; Baert AL; van der Schueren E
AJR Am J Roentgenol; 1989 Apr; 152(4):771-5. PubMed ID: 2784260
[TBL] [Abstract][Full Text] [Related]
27. Superparamagnetic iron oxide-enhanced magnetic resonance imaging of the liver in beagle dogs.
Chang D; Kim B; Yun Y; Hur Y; Lee Y; Choi M; Yoon J; Seong J
Vet Radiol Ultrasound; 2002; 43(1):37-42. PubMed ID: 11866042
[TBL] [Abstract][Full Text] [Related]
28. MR imaging of splenic metastases: ferrite-enhanced detection in rats.
Weissleder R; Hahn PF; Stark DD; Rummeny E; Saini S; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Oct; 149(4):723-6. PubMed ID: 3498320
[TBL] [Abstract][Full Text] [Related]
29. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
Leveille-Webster CR; Rogers J; Arias IM
Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals.
Frank H; Weissleder R; Brady TJ
AJR Am J Roentgenol; 1994 Jan; 162(1):209-13. PubMed ID: 8273667
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacological properties of complex iron oxide nanoparticles entering in magnetic resonance tomography contrast agent].
Akopdzhanov AG; Sergeev AI; Manvelov EV; Semeĭkin AV; Naumenko VIu; Panov VO; Bykov IV; Shimanovskiĭ NL
Eksp Klin Farmakol; 2010 Jun; 73(6):23-8. PubMed ID: 20726347
[TBL] [Abstract][Full Text] [Related]
32. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system.
Bjørnerud A; Johansson L
NMR Biomed; 2004 Nov; 17(7):465-77. PubMed ID: 15526351
[TBL] [Abstract][Full Text] [Related]
33. Paramagnetic macrocyclic complexes as contrast agents for MR imaging: proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues.
Jackels SC; Kroos BR; Hinson WH; Karstaedt N; Moran PR
Radiology; 1986 May; 159(2):525-30. PubMed ID: 3961187
[TBL] [Abstract][Full Text] [Related]
34. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.
Lee PW; Hsu SH; Wang JJ; Tsai JS; Lin KJ; Wey SP; Chen FR; Lai CH; Yen TC; Sung HW
Biomaterials; 2010 Feb; 31(6):1316-24. PubMed ID: 19959224
[TBL] [Abstract][Full Text] [Related]
35. Splenic lymphoma: ferrite-enhanced MR imaging in rats.
Weissleder R; Stark DD; Rummeny EJ; Compton CC; Ferrucci JT
Radiology; 1988 Feb; 166(2):423-30. PubMed ID: 3336717
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of accumulation of small particles of iron oxide in experimentally induced osteosarcomas of rats: a correlation of magnetic resonance imaging and histology. Preliminary results.
Axmann C; Bohndorf K; Gellissen J; Prescher A; Lodemann KP
Invest Radiol; 1998 Apr; 33(4):236-45. PubMed ID: 9556749
[TBL] [Abstract][Full Text] [Related]
37. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.
Wang YX; Hussain SM; Krestin GP
Eur Radiol; 2001; 11(11):2319-31. PubMed ID: 11702180
[TBL] [Abstract][Full Text] [Related]
38. Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers.
Päuser S; Reszka R; Wagner S; Wolf KJ; Buhr HJ; Berger G
Anticancer Drug Des; 1997 Mar; 12(2):125-35. PubMed ID: 9113067
[TBL] [Abstract][Full Text] [Related]
39. Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies.
Hahn PF; Stark DD; Saini S; Lewis JM; Wittenberg J; Ferrucci JT
Radiology; 1987 Jul; 164(1):37-41. PubMed ID: 3588924
[TBL] [Abstract][Full Text] [Related]
40. Experimental study of the pharmacokinetics and dose response of ferrite particles used as a contrast agent in MRI of the normal liver of the rabbit.
Van Hecke P; Marchal G; Decrop E; Baert AL
Invest Radiol; 1989 May; 24(5):397-9. PubMed ID: 2745023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
